UBS Group’s ERBA DIAGNOSTICS ERB Stock Holding History

UBS Group’s Portfolio ERB Stock Details ERB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,339	Closed	-$3K	–	8237
2016 Q2	$3K	Buy	4,339 +1,740	+67%	+$1.72K	﹤0.01%	7390
2016 Q1	$3K	Sell	2,599 -1,659	-39%	-$2K	﹤0.01%	7263
2015 Q4	$6K	Buy	+4,258	New	+$7.1K	﹤0.01%	7654
2015 Q3	–	Sell	-1,187	Closed	-$3K	–	8901
2015 Q2	$3K	Buy	+1,187	New	+$3.53K	﹤0.01%	8135

Other funds holding ERB

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

VIA

Vantage Investment Advisors State College, Pennsylvania $477M AUM 17.38% 1-Year Est. Return

UBS Group's ERB Position: Q3 2016 in Review

UBS Group sold out of ERBA DIAGNOSTICS (ERB) in Q3 2016, closing a stake of 4,339 shares — an estimated $3K sold.

UBS Group first reported a position in ERB in Q2 2015 and held it in 4 quarters. The position peaked at $6K in Q4 2015. 2 funds tracked by Wall St. Rank hold ERB as of Q3 2016.

UBS Group reported no remaining ERBA DIAGNOSTICS position as of Q3 2016 after selling out during the quarter.
UBS Group sold 4,339 ERBA DIAGNOSTICS shares in Q3 2016, an estimated $3K.
UBS Group first reported a position in ERBA DIAGNOSTICS in Q2 2015 and held it in 4 quarters.
UBS Group's ERBA DIAGNOSTICS position peaked at $6K in Q4 2015.
2 funds tracked by Wall St. Rank held ERBA DIAGNOSTICS as of Q3 2016.

Based on UBS Group's 13F filing for Q3 2016, filed 14 Nov 2016.